Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01013311 · ClinicalTrials.gov registry record

Implantable Cardiac Defibrillators for the Prevention of Sudden Death in Patients With Cardiac Sarcoidosis

A clinical trial, sponsored by Virginia Commonwealth University.

Completed
Registry status
10
Enrollment target

NCT01013311: Completed study, sponsored by Virginia Commonwealth University.

NCT01013311 is a clinical trial that has completed, run by Virginia Commonwealth University. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01013311 has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
10 participants
Enrollment target

Study Summary

The purpose of this study is to identify patients with cardiac sarcoidosis who may be at risk for sudden death.

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2009-11
Est. Completion 2010-12
Virginia Commonwealth University

558 total trials

What the finished NCT01013311 record still lists

NCT01013311 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01013311 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01013311 about?

NCT01013311 is a clinical study titled "Implantable Cardiac Defibrillators for the Prevention of Sudden Death in Patients With Cardiac Sarcoidosis". The purpose of this study is to identify patients with cardiac sarcoidosis who may be at risk for sudden death.

What is the current status of trial NCT01013311?

This trial is currently completed. The enrollment target is 10 participants. The study started on 2009-11. Estimated completion is 2010-12.

Who is sponsoring clinical trial NCT01013311?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01013311, the US trial registry maintained by the National Library of Medicine. NCT01013311 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.